Teresa Santantonio

10.0k total citations · 3 hit papers
148 papers, 6.3k citations indexed

About

Teresa Santantonio is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Teresa Santantonio has authored 148 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Hepatology, 108 papers in Epidemiology and 42 papers in Infectious Diseases. Recurrent topics in Teresa Santantonio's work include Hepatitis C virus research (103 papers), Hepatitis B Virus Studies (95 papers) and Liver Disease Diagnosis and Treatment (65 papers). Teresa Santantonio is often cited by papers focused on Hepatitis C virus research (103 papers), Hepatitis B Virus Studies (95 papers) and Liver Disease Diagnosis and Treatment (65 papers). Teresa Santantonio collaborates with scholars based in Italy, Germany and United States. Teresa Santantonio's co-authors include Helmut M. Diepolder, Roman Zachoval, Robert M. Hoffmann, Giuseppe Pastore, Gerd R. Pape, G. R. Pape, Winfried Schraut, E A Wierenga, Norbert H. Gruener and J. Tilman Gerlach and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Teresa Santantonio

145 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1995 586 citations Teresa Santantonio et al. profile →
Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C

1999 580 citations Teresa Santantonio et al. profile →
Treatment of Acute Hepatitis C with Interferon Alfa-2b

2001 516 citations Heiner Wedemeyer, Teresa Santantonio et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Teresa Santantonio Italy	36	5.4k	4.7k	1.1k	733	499	148	6.3k
Margaret James Koziel United States	42	5.1k 0.9×	4.4k 0.9×	1.4k 1.3×	1.1k 1.5×	509 1.0×	98	6.8k
C. Trépo France	46	9.4k 1.8×	9.1k 1.9×	737 0.7×	1.2k 1.7×	721 1.4×	200	11.2k
Ola Weiland Sweden	47	7.6k 1.4×	7.2k 1.5×	611 0.6×	1.5k 2.0×	855 1.7×	254	9.2k
Chloe L. Thio United States	50	6.7k 1.2×	6.7k 1.4×	1.8k 1.7×	2.0k 2.7×	537 1.1×	154	9.4k
Leslie H. Tobler United States	37	2.8k 0.5×	3.0k 0.6×	606 0.6×	1.6k 2.1×	339 0.7×	74	5.2k
Daryl Lau United States	35	3.6k 0.7×	3.8k 0.8×	1.0k 1.0×	612 0.8×	215 0.4×	108	5.1k
Michaela Lucas Australia	34	1.9k 0.4×	1.4k 0.3×	1.8k 1.7×	501 0.7×	334 0.7×	140	4.2k
Juan Ignacio Esteban Spain	36	3.8k 0.7×	3.3k 0.7×	195 0.2×	838 1.1×	264 0.5×	109	4.8k
Peter Karayiannis United Kingdom	40	5.9k 1.1×	6.2k 1.3×	405 0.4×	1.0k 1.4×	126 0.3×	179	7.2k
Giovanni Raimondo Italy	44	6.4k 1.2×	7.0k 1.5×	464 0.4×	624 0.9×	200 0.4×	159	8.2k

Countries citing papers authored by Teresa Santantonio

Since Specialization

Citations

This map shows the geographic impact of Teresa Santantonio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Santantonio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Santantonio more than expected).

Fields of papers citing papers by Teresa Santantonio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresa Santantonio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Santantonio. The network helps show where Teresa Santantonio may publish in the future.

Co-authorship network of co-authors of Teresa Santantonio

This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Santantonio. A scholar is included among the top collaborators of Teresa Santantonio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Santantonio. Teresa Santantonio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reiners, Katrin S., et al.. (2025). Expression Analysis of let-7a-5p and miR-21-3p in Extracellular Vesicles Derived from Serum of NSCLC Patients. Biomedicines. 13(9). 2060–2060.

Ciccarese, Giulia, Antonio Di Biagio, Francesco Drago, et al.. (2023). Monkeypox virus infection mimicking primary syphilis. Infezioni in Medicina. 31(1). 113–115. 6 indexed citations

Mazzola, Michele, et al.. (2023). Clinical Characteristics, Outcomes, and Risk Factors of Patients Hospitalized for COVID-19 across the Latest Pandemic Waves: Has Something Changed?. SHILAP Revista de lepidopterología. 3(2). 272–281. 1 indexed citations

Saulle, Irma, Micaela Garziano, Gioia Cappelletti, et al.. (2023). Salivary miRNA Profiles in COVID-19 Patients with Different Disease Severities. International Journal of Molecular Sciences. 24(13). 10992–10992. 9 indexed citations

Fasano, M., et al.. (2022). Management of Chronic Hepatitis B in HIV-Coinfected Patients. Viruses. 14(9). 2022–2022. 6 indexed citations

Vito, Andrea De, Mariangela Valentina Puci, Teresa Santantonio, et al.. (2022). Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case–control study. Current Medical Research and Opinion. 38(12). 2029–2033. 10 indexed citations

Scioscia, Giulia, Maria Rosaria Capobianchi, Donato Lacedonia, et al.. (2021). Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2?. Journal of Clinical Medicine. 10(2). 309–309. 20 indexed citations

Vichi, Francesca, Antonio Di Biagio, Marco Berruti, et al.. (2021). General Practitioners as partners for a shared management of chronic HIV infection: An insight into the perspectives of Italian People Living with HIV. PLoS ONE. 16(7). e0254404–e0254404. 1 indexed citations

Gallo, Crescenzio, et al.. (2021). Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic. Antibiotics. 10(12). 1477–1477. 4 indexed citations

10.

Torretta, Enrica, Micaela Garziano, Daniele Capitanio, et al.. (2021). Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature. International Journal of Molecular Sciences. 22(19). 10198–10198. 45 indexed citations

11.

Rossetti, Barbara, Velia Chiara Di Maio, Stefania Paolucci, et al.. (2021). Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019.. PubMed. 29(2). 242–251. 1 indexed citations

12.

Fortunato, Francesca, Domenico Martinelli, Sergio Lo Caputo, et al.. (2021). Sex and gender differences in COVID-19: an Italian local register-based study. BMJ Open. 11(10). e051506–e051506. 24 indexed citations

13.

Bavaro, Davide Fiore, Claudia Fabrizio, Carmen Rita Santoro, et al.. (2020). Tocilizumab and corticosteroids for COVID-19 treatment in elderly patients. CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro). 68(4). 197–203. 10 indexed citations

14.

Raghwani, Jayna, Rebecca Rose, Isabelle Sheridan, et al.. (2016). Exceptional Heterogeneity in Viral Evolutionary Dynamics Characterises Chronic Hepatitis C Virus Infection. PLoS Pathogens. 12(9). e1005894–e1005894. 29 indexed citations

15.

Andriulli, Angelo, Filomena Morisco, A Ippolito, et al.. (2014). HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome. Hepatology International. 9(1). 52–57. 6 indexed citations

16.

Fattovich, G., Loredana Covolo, Stéphanie Bibert, et al.. (2011). IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 33(10). 1162–1172. 82 indexed citations

17.

Reijnders, Jurriën G.P., Katja Deterding, Jörg Petersen, et al.. (2010). Antiviral effect of entecavir in chronic hepatitis B: Influence of prior exposure to nucleos(t)ide analogues. Journal of Hepatology. 52(4). 493–500. 85 indexed citations

18.

Santantonio, Teresa, A. Guastadisegni, C Casalino, et al.. (2003). Natural course of acute hepatitis C: a long-term prospective study. Digestive and Liver Disease. 35(2). 104–113. 75 indexed citations

19.

Milella, Michele Stanislaw, Guido Antonelli, Teresa Santantonio, et al.. (1995). Treatment with natural IFN of hepatitis C patients with or without antibodies to recombinant IFN.. PubMed. 42(3). 201–4. 21 indexed citations

20.

Pastore, Giuseppe, Teresa Santantonio, Michele Stanislaw Milella, et al.. (1992). Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon. Journal of Hepatology. 14(2-3). 221–225. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact